Linkage of acquired quinolone resistance (qnrS1) and metallo-beta-lactamase (blaVIM-1) genes in multiple species of Enterobacteriaceae from Bolzano, Italy

The Journal of Antimicrobial Chemotherapy
Richard AschbacherNeil Woodford

Abstract

Twenty-four of 209 oxyimino-cephalosporin- and/or aztreonam-resistant Enterobacteriaceae collected around Bolzano had reduced susceptibility or resistance to carbapenems and gave positive metallo-beta-lactamase (MBL) tests. Their resistance mechanisms were investigated. Resistances were identified by Vitek 2 and MIC tests and isolates were genotyped by PFGE. Resistance genes were identified by PCR and sequencing, and plasmids were transferred by conjugation and/or transformation. Plasmid-borne genes were identified by Southern blotting, and their genetic surroundings were investigated by PCR mapping. The 24 isolates with positive EDTA/imipenem synergy tests had bla(VIM-1) carried on 40-150 kb plasmids. Imipenem MICs ranged from 2 to >32 mg/L, while those of meropenem and ertapenem were lower. The isolates included a clonal cluster of 10 Klebsiella pneumoniae, two other K. pneumoniae isolates, and diverse isolates of Escherichia coli (seven), Klebsiella oxytoca (three) and Citrobacter freundii (two). Six MBL producers were aztreonam-susceptible; the 18 aztreonam-resistant isolates had co-resident extended-spectrum beta-lactamases. bla(VIM-1) occurred as the first cassette in class 1 integrons, with aacA4 as the second cassette. ...Continue Reading

Citations

Apr 15, 2011·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·L SorlíJ P Horcajada
Jul 11, 2013·The Journal of Antibiotics·Aysegul Copur CicekCemal Sandalli
Aug 19, 2009·The Journal of Antimicrobial Chemotherapy·David M Livermore
Sep 24, 2008·Antimicrobial Agents and Chemotherapy·Gian Maria RossoliniLaura Pagani
Oct 16, 2015·Microbial Drug Resistance : MDR : Mechanisms, Epidemiology, and Disease·Xiao-Ying PuHua Yu
Jul 4, 2009·Journal of Medical Microbiology·Nashwan Al NaiemiYvette J Debets-Ossenkopp
Nov 3, 2012·Journal of Medical Microbiology·Béla KocsisAnnarita Mazzariol
Jun 24, 2014·BioMed Research International·Nassima DjahmiJean-Philippe Lavigne
Jul 9, 2016·Critical Reviews in Microbiology·Najla MathlouthiChedly Chouchani
Feb 14, 2009·Infection Control and Hospital Epidemiology : the Official Journal of the Society of Hospital Epidemiologists of America·Leonardo PaganiRichard Aschbacher
Oct 14, 2008·Expert Review of Anti-infective Therapy·Luis Martínez-MartínezAlvaro Pascual
Aug 7, 2010·Expert Opinion on Therapeutic Patents·Guilherme H Furtado, David P Nicolau
Jan 15, 2015·Microbiology Spectrum·George A JacobyDavid C Hooper

❮ Previous
Next ❯

Related Concepts

Related Feeds

Carbapenems

Carbapenems are members of the beta lactam class of antibiotics and are used for the treatment of severe or high-risk bacterial infections. Discover the latest research on carbapenems here.

Aminoglycosides

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Carbapenems (ASM)

Carbapenems are members of the beta lactam class of antibiotics and are used for the treatment of severe or high-risk bacterial infections. Discover the latest research on carbapenems here.

Aminoglycosides (ASM)

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.